Oppenheimer Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.45M Buy
39,843
+984
+3% +$181K 0.08% 284
2026
Q1
$7.33M Sell
38,859
-6,738
-15% -$1.42M 0.08% 266
2025
Q4
$9.06M Sell
45,597
-4,894
-10% -$989K 0.11% 209
2025
Q3
$10.3M Sell
50,491
-7,774
-13% -$1.38M 0.11% 204
2025
Q2
$10.3M Buy
58,265
+30,182
+107% +$4.54M 0.12% 200
2025
Q1
$3.78M Buy
+28,083
New +$3.7M 0.05% 377
2023
Q3
– Sell
-3,063
Closed -$249K – 1161
2023
Q2
$249K Sell
3,063
-527
-15% -$37.5K ﹤0.01% 1011
2023
Q1
$213K Buy
+3,590
New +$200K ﹤0.01% 1042

Other funds holding THC

Oppenheimer Asset Management's THC Position: Q2 2026 in Review

Oppenheimer Asset Management increased its Tenet Healthcare (THC) stake by 2.5% in Q2 2026, buying an estimated $181K and bringing the position to 39,843 shares worth $7.45M. The position accounts for 0.08% of the portfolio, ranked #284.

Oppenheimer Asset Management first reported a position in THC in Q1 2023 and has held it in 8 quarters since. The position peaked at $10.3M in Q2 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Oppenheimer Asset Management held 39,843 shares of Tenet Healthcare worth $7.45M as of Q2 2026.
  • Oppenheimer Asset Management bought 984 Tenet Healthcare shares in Q2 2026, an estimated $181K.
  • Tenet Healthcare made up 0.08% of Oppenheimer Asset Management's portfolio in Q2 2026, its #284 holding.
  • Oppenheimer Asset Management first reported a position in Tenet Healthcare in Q1 2023 and has held it in 8 quarters since.
  • Oppenheimer Asset Management's Tenet Healthcare position peaked at $10.3M in Q2 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.